LEXISCAN is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Regadenoson.
Product ID | 0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10 |
NDC | 0469-6501 |
Product Type | Human Prescription Drug |
Proprietary Name | LEXISCAN |
Generic Name | Regadenoson |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2008-04-10 |
Marketing Category | NDA / NDA |
Application Number | NDA022161 |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | REGADENOSON |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2008-04-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022161 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-04-10 |
Marketing End Date | 2011-10-20 |
Marketing Category | NDA |
Application Number | NDA022161 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-04-10 |
Ingredient | Strength |
---|---|
REGADENOSON | .08 mg/mL |
SPL SET ID: | 057289f4-2e18-4c1e-bed4-6c1858e2ef16 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0469-6501 | LEXISCAN | regadenoson |
55150-443 | regadenoson | regadenoson |
68083-175 | Regadenoson | Regadenoson |
71288-201 | Regadenoson | Regadenoson |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LEXISCAN 78890527 3503116 Live/Registered |
Astellas US LLC 2006-05-23 |